Hodgkin Lymphoma

Surgery · 2014

A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Hodgkin Lymphoma trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. J. Prat
  2. Mitchell Dowsett
  3. R. Sylvester
  4. J. Baselga
  5. R. Kurman
  6. C. Fletcher
  7. M. R. D. Christenson
  8. B. Rini
  9. Jonathan A. Ledermann
  10. B. Leibovich

Papers from Hodgkin Lymphoma's perspective

Ordered by how strongly the researchers Hodgkin Lymphoma trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Nonparametric Estimation from Incomplete Observations
  2. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer… (Journal of the National Cancer Institute)
  3. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. (New England Journal of Medicine)
  4. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. (New England Journal of Medicine)
  5. Molecular portraits of human breast tumours (Nature)
  6. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. (New England Journal of Medicine)
  7. PD-1 blockade in tumors with mismatch repair deficiency. (Journal of Clinical Oncology)
  8. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. (New England Journal of Medicine)
  9. Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. (The Lancet)
  10. Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing (New England Journal of Medicine)

Their papers